• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征的细胞遗传学

The cytogenetics of myelodysplastic syndromes.

作者信息

Olney H J, Le Beau M M

机构信息

Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland, MC 2115, Chicago, Illinois 60637, USA.

出版信息

Best Pract Res Clin Haematol. 2001 Sep;14(3):479-95. doi: 10.1053/beha.2001.0151.

DOI:10.1053/beha.2001.0151
PMID:11640866
Abstract

The myelodysplastic syndromes are a collection of five clinico-pathological entities with a wide spectrum of clinical behaviours and survival outcomes. Cytogenetic analysis has been instrumental in refining the prognosis, predicting the likelihood of progression to acute myeloid leukaemia and median survival, and in establishing clonality of these diseases. This review highlights the most frequent abnormalities and summarizes their clinical and genetic features.

摘要

骨髓增生异常综合征是一组包含五个临床病理实体的疾病,具有广泛的临床行为和生存结局。细胞遗传学分析有助于完善预后评估、预测进展为急性髓系白血病的可能性及中位生存期,并有助于确定这些疾病的克隆性。本综述重点介绍了最常见的异常情况,并总结了它们的临床和遗传学特征。

相似文献

1
The cytogenetics of myelodysplastic syndromes.骨髓增生异常综合征的细胞遗传学
Best Pract Res Clin Haematol. 2001 Sep;14(3):479-95. doi: 10.1053/beha.2001.0151.
2
Clinical relevance of cytogenetics in myelodysplastic syndromes.细胞遗传学在骨髓增生异常综合征中的临床相关性。
Ann N Y Acad Sci. 2006 Nov;1089:395-410. doi: 10.1196/annals.1386.034.
3
[Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].[骨髓增生异常综合征的诊断与预后。细胞遗传学的影响]
Recenti Prog Med. 2014 Mar;105(3):110-4. doi: 10.1701/1434.15871.
4
[Significance, diagnosis and prognosis in the cytogenetic analysis in acute leukemias and myelodysplastic syndromes].
Ther Umsch. 1996 Feb;53(2):103-10.
5
Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.巴西帕拉州骨髓增生异常综合征体征和症状患者的细胞遗传学特征。
Genet Mol Res. 2005 Mar 31;4(1):18-30.
6
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.世界卫生组织分类与细胞遗传学标志物相结合可改善初发原发性骨髓增生异常综合征患者的预后分层。
Br J Haematol. 2007 May;137(3):193-205. doi: 10.1111/j.1365-2141.2007.06537.x.
7
[Cytogenetics in the study of malignant blood diseases].[恶性血液病研究中的细胞遗传学]
Sangre (Barc). 1996 Aug;41(4):289-95.
8
Cytogenetics.细胞遗传学
Hematol Oncol Clin North Am. 1992 Jun;6(3):523-41.
9
Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.与5号染色体长臂间质性缺失相关的骨髓增生异常综合征:临床病理相关性及来那度胺治疗前时代的新见解
Am J Hematol. 2008 Sep;83(9):708-13. doi: 10.1002/ajh.21245.
10
Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.伴有急性髓系白血病倾向的家族性血小板疾病:遗传异质性及通过获得克隆性染色体异常进展为白血病
Genes Chromosomes Cancer. 2004 Jul;40(3):165-71. doi: 10.1002/gcc.20030.

引用本文的文献

1
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes.一个独特的表观遗传程序为骨髓增生异常综合征中的 1;7 易位奠定了基础。
Leukemia. 2019 Oct;33(10):2481-2494. doi: 10.1038/s41375-019-0433-9. Epub 2019 Mar 28.
2
Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.Mdm2基因发生突变且该突变干扰MDM2与核糖体蛋白结合的小鼠,其红细胞生成出现缺陷。
PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016.
3
Carcinogenesis: alterations in reciprocal interactions of normal functional structure of biologic systems.
致癌作用:生物系统正常功能结构的相互作用发生改变。
EURASIP J Bioinform Syst Biol. 2015 Nov 18;2015(1):11. doi: 10.1186/s13637-015-0030-9. eCollection 2015 Dec.
4
The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes.磁共振成像在骨髓增生异常综合征输血性铁过载评估中的作用
Rev Bras Hematol Hemoter. 2015 Jul-Aug;37(4):252-8. doi: 10.1016/j.bjhh.2015.03.014. Epub 2015 May 19.
5
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.通过下一代测序技术对治疗相关骨髓增生异常综合征和急性髓系白血病进行突变分析,并与初发性疾病进行比较。
Leuk Res. 2015 Mar;39(3):348-54. doi: 10.1016/j.leukres.2014.12.006. Epub 2014 Dec 20.
6
Bone marrow and karyotype findings of patients with pancytopenia in southern iran.伊朗南部全血细胞减少症患者的骨髓和核型分析结果
Iran J Med Sci. 2014 Jul;39(4):333-40.
7
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.一种用于预测治疗相关骨髓增生异常综合征生存及转化为急性髓系白血病的预后模型。
Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):401-10. doi: 10.1016/j.clml.2014.03.001. Epub 2014 May 6.
8
Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome.低危骨髓增生异常综合征中核糖体蛋白基因剂量降低和 p53 激活。
Blood. 2011 Sep 29;118(13):3622-33. doi: 10.1182/blood-2010-11-318584. Epub 2011 Jul 25.
9
Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?骨髓增生异常综合征与组蛋白去乙酰化酶抑制剂:“乙酰化与否”?
J Biomed Biotechnol. 2011;2011:214143. doi: 10.1155/2011/214143. Epub 2011 May 15.
10
Myelodysplastic syndromes: an update on molecular pathology.骨髓增生异常综合征:分子病理学的最新进展。
Clin Transl Oncol. 2010 Oct;12(10):652-61. doi: 10.1007/s12094-010-0574-9.